Endpoints @ JPM26 Panel featuring Lars Petersen

Manufacturing During Global Policy Uncertainty

Amid rising tariff pressures and shifting global policies, biopharma manufacturers are rethinking where and how therapies are produced. As companies invest in US-based capacity and reconfigure supply chains, uncertainty remains a defining challenge. In this Endpoints panel, Lars Petersen, President & CEO of FUJIFILM Biotechnologies, joins industry leaders from Bristol Myers Squibb and Novartis to explore how organizations are building resilience, maintaining supply continuity, and advancing manufacturing strategies in a rapidly evolving global landscape.